Maaike E. Ressing

5.6k citations
75 papers · 4.6k · h-index 37

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 1%
    • Viral-associated cancers and disorders

Papers in

  • Immunology 54
    • Immune Cell Function and Interaction 24
    • Immunotherapy and Immune Responses 21
    • interferon and immune responses 8
  • Epidemiology 51
    • Cytomegalovirus and herpesvirus research 35
    • Herpesvirus Infections and Treatments 20
    • Cervical Cancer and HPV Research 9
Co-authors
Emmanuel J. H. J. Wiertz (41 shared papers)Daphne van Leeuwen (13 shared papers)W. Martin Kast (12 shared papers)Daniëlle Horst (13 shared papers)Martin Rowe (7 shared papers)Remco M.P. Brandt (9 shared papers)Bryan D. Griffin (6 shared papers)Jianmin Zuo (4 shared papers)
Journals
The Journal of Immunology (12 papers)PLoS Pathogens (7 papers)Journal of Virology (7 papers)Molecular Immunology (5 papers)Proceedings of the National Academy of Sciences (4 papers)
Partner nations
NetherlandsUnited StatesGermany

In The Last Decade

Maaike E. Ressing

73 papers receiving 4.5k citations

Peers

Maaike E. Ressing
Comparison fields: 5 of 101
  • Immunology 2.7k
  • Oncology 1.7k
  • Epidemiology 2.1k
  • Virology 200
  • Pathology and Forensic Medicine 339
Replace Ian A. York with:
Ian A. York United States
Tatsuya Tsurumi Japan
Benjamin E. Gewurz United States
Kiyotaka Kuzushima Japan
Graham R. Leggatt Australia
Michael G. Kurilla United States
Mitsuharu Sato Japan
Bjarne Bogen Norway
Joshy Jacob United States
Stephen Man United Kingdom
Maaike E. Ressing relative to Ian A. York United States Ian A. York's profile →
Citations per field
00.5×1.5×2.1×
Ian A. York · 1×
Citations per year

Countries citing papers authored by Maaike E. Ressing

Since Specialization
Citations

This map shows the geographic impact of Maaike E. Ressing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maaike E. Ressing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maaike E. Ressing more than expected).

Fields of papers citing papers by Maaike E. Ressing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maaike E. Ressing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maaike E. Ressing. The network helps show where Maaike E. Ressing may publish in the future.

Co-authors

The 25 scholars most cited alongside Maaike E. Ressing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maaike E. Ressing Line = papers co-authored together Maaike E. Ressing links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
The Journal of Immunology ·Maaike E. Ressing, Alessandro Sette, Remco M.P. Brandt, J Ruppert, Peggy Wentworth, M. Hartman, Carla Oseroff, H M Grey, Cornelis J.M. Melief, W. Martin Kast
1995336
2
Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion
Proceedings of the National Academy of Sciences ·Martin Rowe, Britt A. Glaunsinger, Daphne van Leeuwen, Jianmin Zuo, David A. Sweetman, Don Ganem, Jaap M. Middeldorp, Emmanuel J. H. J. Wiertz, Maaike E. Ressing
2007199
3
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial
European Journal of Cancer ·Willemien J. van Driel, Maaike E. Ressing, Gemma G. Kenter, Remco M.P. Brandt, E. J. T. Krul, A.B. van Rossum, Ed Schuuring, Rienk Offringa, Thomas Bauknecht, A. Tamm-Hermelink, Peter A. van Dam, Gert Jan Fleuren, W. Martin Kast, C J Melief, J. Baptist Trimbos
1999193
4
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.
PubMed ·Maaike E. Ressing, Willemien J. van Driel, Esteban Celis, Angelica Sette, M P Brandt, M. Hartman, J D Anholts, G. M. T. Schreuder, W B ter Harmsel, Gert Jan Fleuren, B J Trimbos, W. Martin Kast, Cornelis J.M. Melief
1996164
5
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing
Proceedings of the National Academy of Sciences ·Danijela Koppers‐Lalic, Eric A. Reits, Maaike E. Ressing, Andrea D. Lipińska, Rupert Abele, Joachim Koch, Marisa Marcondes Rezende, Pieter Admiraal, Daphne van Leeuwen, Krystyna Bieńkowska-Szewczyk, Thomas C. Mettenleiter, Frans A.M. Rijsewijk, Robert Tampé, Jacques Neefjes, Emmanuel J. H. J. Wiertz
2005161
6
Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
PubMed ·Koji Kono, Maaike E. Ressing, Remco M.P. Brandt, C J Melief, Ronald K. Potkul, Birger Andersson, Max Petersson, W. Martin Kast, Rolf Kiessling
1996152
7
The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation
PLoS Pathogens ·Jianmin Zuo, Andrew Currin, Bryan D. Griffin, Claire Shannon‐Lowe, Wendy A. Thomas, Maaike E. Ressing, Emmanuel J. H. J. Wiertz, Martin Rowe
2009150
8
Detection of T Helper Responses, But Not of Human Papillomavirus-Specific Cytotoxic T Lymphocyte Responses, After Peptide Vaccination of Patients With Cervical Carcinoma
Journal of Immunotherapy ·Maaike E. Ressing, Willemien J. van Driel, Remco M.P. Brandt, Gemma G. Kenter, Joan H. de Jong, Thomas Bauknecht, G. J. Fleuren, Peter Hoogerhout, Rienk Offringa, Alessandro Sette, Esteban Celis, Howard M. Grey, Baptist Trimbos, W. Martin Kast, Cornelis J.M. Melief
2000149
9
A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
The Journal of Experimental Medicine ·Andrew D. Hislop, Maaike E. Ressing, Daphne van Leeuwen, Victoria A. Pudney, Daniëlle Horst, Danijela Koppers‐Lalic, Nathan P. Croft, Jacques Neefjes, Alan B. Rickinson, Emmanuel J. H. J. Wiertz
2007148
10
Natural T-helper immunity against human papillomavirus type 16 (hpv16) e7-derived peptide epitopes in patients with hpv16-positive cervical lesions: Identification of 3 human leukocyte antigen class ii-restricted epitopes
International Journal of Cancer ·Sjoerd H. van der Burg, Maaike E. Ressing, Kitty M.C. Kwappenberg, Annemieke de Jong, Karin Straathof, Joan de Jong, Annemieke Geluk, Krista E. van Meijgaarden, Kees L. M. C. Franken, Tom H. M. Ottenhoff, Gert Jan Fleuren, Gemma G. Kenter, Cornelis J.M. Melief, Rienk Offringa
2001130
11
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells.
PubMed ·M L De Bruijn, Danita H. Schuurhuis, Michel Vierboom, Hester Vermeulen, K A de Cock, Marlies E. Ooms, Maaike E. Ressing, Mireille Toebes, Kees L. M. C. Franken, Jan W. Drijfhout, Tom H. M. Ottenhoff, Rienk Offringa, Cornelis J.M. Melief
1998126
12
Immune Evasion by Epstein-Barr Virus
Current topics in microbiology and immunology ·Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein J. G. Hooykaas, Sytse J. Piersma, Emmanuel J. H. J. Wiertz
2015124
13
Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
PLoS Pathogens ·Michiel van Gent, Steven Braem, Annemieke de Jong, Nezira Delagic, Janneke G. C. Peeters, Ingrid G. J. Boer, Paul N. Moynagh, Elisabeth Kremmer, Emmanuel J. H. J. Wiertz, Huib Ovaa, Bryan D. Griffin, Maaike E. Ressing
2014120
14
Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products
Seminars in Cancer Biology ·Maaike E. Ressing, Daniëlle Horst, Bryan D. Griffin, Judy Tellam, Jianmin Zuo, Rajiv Khanna, Martin Rowe, Emmanuel J. H. J. Wiertz
2008108
15
CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.
The Journal of Immunology ·Marjan J.W. Visseren, A van Elsas, E.I. van der Voort, Maaike E. Ressing, W. Martin Kast, Peter I. Schrier, C J Melief
1995104
16
A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation
Nature Communications ·Michael L. van de Weijer, Michael C. Bassik, Rutger D. Luteijn, Cornelia M. Voorburg, Mirjam A. M. Lohuis, Elisabeth Kremmer, Rob C. Hoeben, Emily M LeProust, Siyuan Chen, Hanneke Hoelen, Maaike E. Ressing, Weronika Patena, Jonathan S. Weissman, Michael T. McManus, Emmanuel J. H. J. Wiertz, Robert Jan Lebbink
201498
17
Epstein-Barr Virus gp42 Is Posttranslationally Modified To Produce Soluble gp42 That Mediates HLA Class II Immune Evasion
Journal of Virology ·Maaike E. Ressing, Daphne van Leeuwen, Frank A. W. Verreck, Sinéad E. Keating, Raquel Gomez, Kees L. M. C. Franken, Tom H. M. Ottenhoff, Melanie K. Spriggs, Ton N. Schumacher, Lindsey Hutt‐Fletcher, Martin Rowe, Emmanuel J. H. J. Wiertz
200488
18
Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition
Proceedings of the National Academy of Sciences ·Maaike E. Ressing, Daphne van Leeuwen, Frank A. W. Verreck, Raquel Gomez, Bianca Heemskerk, Mireille Toebes, Maureen M. Mullen, Theodore S. Jardetzky, Richard Longnecker, Marco W. Schilham, Tom H. M. Ottenhoff, Jacques Neefjes, Ton N. Schumacher, Lindsey Hutt‐Fletcher, Emmanuel J. H. J. Wiertz
200386
19
EBV MicroRNA BART16 Suppresses Type I IFN Signaling
The Journal of Immunology ·Marjolein J. G. Hooykaas, Michiel van Gent, Jasper A. Soppe, Elisabeth Kruse, Ingrid G. J. Boer, Dik van Leenen, Marian J.A. Groot Koerkamp, Frank C. P. Holstege, Maaike E. Ressing, Emmanuel J. H. J. Wiertz, Robert Jan Lebbink
201786
20
Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation
The Journal of Immunology ·Daniëlle Horst, Daphne van Leeuwen, Nathan P. Croft, Malgorzata Garstka, Andrew D. Hislop, Elisabeth Kremmer, Alan B. Rickinson, Emmanuel J. H. J. Wiertz, Maaike E. Ressing
200986

About Maaike E. Ressing

Maaike E. Ressing is a scholar working on Immunology, Epidemiology, Oncology, Molecular Biology and Genetics, having authored 75 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (35 papers), Viral-associated cancers and disorders (24 papers), Immune Cell Function and Interaction (24 papers), Immunotherapy and Immune Responses (21 papers), Herpesvirus Infections and Treatments (20 papers), Cervical Cancer and HPV Research (9 papers), interferon and immune responses (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (1.7k citations), Epidemiology (2.1k citations), Virology (200 citations) and Pathology and Forensic Medicine (339 citations). Maaike E. Ressing has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Emmanuel J. H. J. Wiertz, Daphne van Leeuwen, W. Martin Kast, Daniëlle Horst, Martin Rowe, Remco M.P. Brandt, Bryan D. Griffin, Jianmin Zuo, Anna M. Gram and Rienk Offringa. Their work appears in journals such as The Journal of Immunology, PLoS Pathogens, Journal of Virology, Molecular Immunology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian A. YorkBreakdown of academic impact, for papers by Tatsuya TsurumiBreakdown of academic impact, for papers by Benjamin E. GewurzBreakdown of academic impact, for papers by Kiyotaka KuzushimaBreakdown of academic impact, for papers by Graham R. LeggattBreakdown of academic impact, for papers by Michael G. KurillaBreakdown of academic impact, for papers by Mitsuharu SatoBreakdown of academic impact, for papers by Bjarne BogenBreakdown of academic impact, for papers by Joshy JacobBreakdown of academic impact, for papers by Stephen Man